Clinical Trials Directory

Trials / Completed

CompletedNCT04853836

Olfactory Disfunction and Co-ultraPEALut

Olfactory Disfunction After COVID-19: Conventional Therapy Versus Intervention Treatment With Co-ultraPEALut

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University Of Perugia · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

Olfactory dysfunction is common among patients with Corona-Virus-Infection-Disease (COVID)-19, and up to 30% of patients may report persistent disorders of smell or taste as a long-term sequelae. This randomized-controlled study has addressed to compare the efficacy of neuro-protective and anti-inflammatory agents palmitoylethanolamide (PEA) and Luteolin(Treatment) with control (olfactory training) in a cohort of patients who present persistent smell disorders after resolution from Covid-19 and negative swab for 4 months at least.

Detailed description

Patients ages 18 to 70 years with confirmed history of COVID-19 (positive nasopharyngeal swab for SARS-CoV-2) and subjective olfactory dysfunction persisting ≥ 90 days after follow-up negative COVID-19 nasopharyngeal swab are eligible. All patients will undergo nasal endoscopic examination to look for presence of polyps, masses, anatomic blockage, or other pathology which presence will require exclusion from the study. Patients then will be evaluated at the baseline with Sniffin' Sticks (Burghardt®, Wedel, Germany) prior to initiating olfactory training and/or supplement treatment (T0). One group received daily olfactory training, patients in the supplement group additionally received a daily oral tablet that contained PEA 700 mg and Luteolin 70 mg (Glialia ®, Epitech pharmaceutical, Milano, Italy), or 1 dose of PEA-LUT only or aTwo Dose of PEA-LUT. Assessment of olfactory function will be repeated at 30 days, 60 and 90 and 120 days

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTco-ultraPEALutOlfactory rehab 10 minutes twice a day for all the observation period + co-ultraPEALut (700 PEA + 70 Luteolin) 1 dose daily.
PROCEDUREOlfactory RehabOlfactory Rehabilitation10 minutes twice a day for all the observation period
DRUGPEA-LUT 1 sachetOnly 1 sachet day of PEA-LUT no olfactory training
DRUGPEA-LUT 2 sachet day2 sachets day of PEA-LUT no olfactory training

Timeline

Start date
2020-11-15
Primary completion
2021-10-28
Completion
2022-08-31
First posted
2021-04-21
Last updated
2022-11-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04853836. Inclusion in this directory is not an endorsement.